APOP Forecast and Technical Stock Analysis
Sell candidate since 2019-08-23
Cellect Biotechnology Ltd fell by -1.68% in the last day ( Friday, 23rd Aug 2019 ) from $0.54 to $0.53 and has now fallen 3 days in a row. During the day the stock fluctuated 7.86% from a day low at $0.51 to a day high of $0.55. The price has fallen in 6 of the last 10 days , but is still up by 26.86% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -22 110 shares and in total 55 108 shares bought and sold for approximately $29 013.30.
- 30 day high of the APOP stock price was $0.92 and low was $0.40.
- 90 day high was $0.92 and low was $0.40.
- 52 week high for Cellect Biotechnology Ltd - $6.01 and low - $0.40.
Cellect Biotechnology Ltd lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.01% during the next 3 months and, with 90% probability hold a price between $0.33 and $0.55 at the end of this period.
Cellect Biotechnology Ltd holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $0.53. On a fall, the stock will find some support from the long-term average at approximately $0.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday August 21, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 52 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Cellect Biotechnology Ltd finds support from accumulated volume at $0.52.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.04 between high and low, or 7.86%. For the last week the stock has had a daily average volatility of 11.35%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
11.35 %Average volatility
Very Low Low Medium High Very High
Cellect Biotechnology Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|APOP $0.53 ($-0.01 -1.68%)|
APOP is down $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for APOP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the APOP analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!